| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 356060-80-5 | Methyl 6-O-[tris(1-methylethyl)silyl]-alpha-D-glucopyranoside tribenzoate | C37H46O9Si |
| 356060-82-7 | Methyl 6-O-[tris(1-methylethyl)silyl]-alpha-D-galactopyranoside tribenzoate | C37H46O9Si |
| 356062-62-9 | 2-[3-(3-Butyl-1,3-dihydro-1,1-dimethyl-2H-benz[e]indol-2-ylidene)-1-propen-1-yl]-1,1,3-trimethyl-1H-benz[e]indolium hexafluorophosphate(1-) (1:1) | C36H39N2.F6P |
| 356068-86-5 | N-(2-(Diethylamino)ethyl)-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide | C14H23N3O2 |
| 356068-93-4 | 5-((Z)-(5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid | C16H13FN2O3 |
| 356068-94-5 | Toceranib | C22H25FN4O2 |
| 356068-97-8 | N-Desethyl-sunitinib | C20H23FN4O2 |
| 356068-99-0 | N-[2-(Diethyloxidoamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide | C22H27FN4O3 |
| 356517-93-6 | 4-[4-[[6-O-(1-Oxo-3-phenyl-2-propenyl)-2-O-(3,4,5-trihydroxybenzoyl)-beta-D-glucopyranosyl]oxy]phenyl]-2-butanone | C32H32O12 |
| 356534-04-8 | (4-Fluoro-2-methylphenyl)hydrazine | C7H9FN2 |
| 356559-20-1 | SB 525334 | C21H21N5 |
| 356560-80-0 | 6-Bromo-[1,2,4]triazolo[1,5-a]pyridine | C6H4BrN3 |
| 356560-84-4 | 1-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-2-(6-methylpyridin-2-yl)ethane-1,2-dione | C14H10N4O2 |
| 356561-08-5 | 5-Iodo-4-methyl-2-pyridinamine | C6H7IN2 |
| 356570-52-0 | 4-Methylbenzylboronic acid pinacol ester | C14H21BO2 |
| 356572-08-2 | 1-Hydroxy-3-amino-5,7-dimethyladamantane hydrochloride | C12H21NO.HCl |
| 356782-84-8 | 3,4-Dihydro-3-oxo-4-beta-D-ribofuranosyl-2-pyrazinecarboxamide | C10H13N3O6 |
| 356783-16-9 | 3,6-Dichloro-2-pyrazinecarbonitrile | C5HCl2N3 |
| 356783-28-3 | 3,6-Difluoro-2-pyrazinecarbonitrile | C5HF2N3 |
| 356783-31-8 | 6-Fluoro-3-oxo-3,4-dihydro-2-pyrazinecarbonitrile | C5H2FN3O |
| 356786-94-2 | Pantothenic acid-13C4,15N hemicalcium salt | 13C6C12H32Ca15N2O10 |
| 357154-27-9 | Ertapenem Ring Open Impurity | C22H27N3O8S |
| 357166-29-1 | Pemetrexed disodium hepthydrate | C20H19N5Na2O6.7(H2O) |
| 357166-30-4 | Pemetrexed disodium hydrate | 2(C20H19N5Na2O6).5(H2O) |
| 357172-63-5 | Morpholine [(5-methyl-1H-1,2,4-triazol-3-yl)thio]acetate | C5H7N3O2S.C4H9NO |
| 357189-94-7 | Posaconazole 3-OXO impurity | C37H40F2N8O5 |
| 357189-95-8 | Posaconazole Impurity B | C37H40F2N8O6 |
| 357209-32-6 | 2,6-Bis[(3aR,8aS)-(+)-8H-indeno[1,2-d]oxazolin-2-yl)pyridine | C25H19N3O2 |
| 357219-41-1 | 9,9-Bis(2-ethylhexyl)fluorene-2,7-bis(boronic acid pinacol ester) | C41H64B2O4 |
| 357263-13-9 | BMS 378806 | C22H22N4O4 |
| 357263-40-2 | 4-Methoxy-1H-pyrrolo[2,3-c]pyridine | C8H8N2O |
| 357263-41-3 | 7-Chloro-1H-pyrrolo[2,3-c]pyridine | C7H5ClN2 |
| 357263-42-4 | 7-Methyl-4-azaindole | C8H8N2 |
| 357263-43-5 | 5-Chloro-7-methyl-1H-pyrrolo[3,2-b]pyridine | C8H7ClN2 |
| 357263-48-0 | 7-Chloro-1H-pyrrolo[3,2-b]pyridine | C7H5ClN2 |
| 357263-49-1 | Methyl 7-azaindole-3-glyoxylate | C10H8N2O3 |
| 357274-85-2 | [1-(Trifluoromethyl)vinyl]boronic acid | C3H4BF3O2 |
| 357289-65-7 | 4-Cyanofuran-2-carboxylic acid methyl ester | C7H5NO3 |
| 357336-20-0 | Brivaracetam | C11H20N2O2 |
| 357336-99-3 | Brivaracetam (alfaR, 4S)-Isomer | C11H20N2O2 |
| 357337-00-9 | Brivaracetam (alfaR, 4R)-Isomer | C11H20N2O2 |
| 357338-13-7 | (alphaS)-alpha-Ethyl-2,5-dihydro-2-oxo-4-propyl-1H-pyrrole-1-acetamide | C11H18N2O2 |
| 357399-43-0 | 2-Hydroxy-2-(3-chlorophenyl)-3,5,5-trimethylmorpholine | C13H18ClNO2 |
| 357405-75-5 | 4-Bromo-2,5-difluorobenzaldehyde | C7H3BrF2O |
| 357426-12-1 | 3-(Aminomethyl)-2,3-dihydro-1H-indene-1-carboxylic acid methyl ester | C12H15NO2 |
| 357437-74-2 | 3,6-Dibromo-9-(4-methylphenyl)-9H-carbazole | C19H13Br2N |
| 357645-16-0 / 145918-59-8 | 6-Hydroxy-4-(4-hydroxy-3-methoxyphenyl)-3-hydroxymethyl-7-methoxy-3,4-dihydro-2-naphthaldehyde | C20H20O6 |
| 357645-37-5 | 2,7-Dibromo-9,9-bis(4-methylphenyl)-9H-fluorene | C27H20Br2 |
| 357645-40-0 | N2,N7-Di-1-naphthalenyl-N2,N7,9,9-tetraphenyl-9H-fluorene-2,7-diamine | C57H40N2 |
| 357927-50-5 | 2-Bromo-4-fluoropyridine | C5H3BrFN |